Position in MGTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$667,123
+$394,940 QoQ
Shares Held
49,380
+57.1% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 156 holders
Holding Since
Sep 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. MGTX ranks #191 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in MGTX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $667,123 | 49,380 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $272,183 | 31,430 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $181,069 | 22,776 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $187,446 | 22,776 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $148,499 | 22,776 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $141,979 | 20,941 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $109,473 | 17,976 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $53,029 | 12,717 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $49,703 | 11,806 | Shares | Defined | 2024-08-14 | |
| 2023-03-31 | $1,657,884 | 320,674 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,615,977 | 707,972 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,555,104 | 1,255,066 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,560,072 | 1,791,291 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $25,054,054 | 1,808,957 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $47,972,486 | 2,020,745 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $26,399,803 | 2,003,020 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $31,098,657 | 2,006,365 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $29,455,857 | 2,041,293 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $30,942,526 | 2,043,760 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $13,204,357 | 997,308 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||